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a b s t r a c t
Objective: Although the exact reason is not known, encapsulated gram-negative Porphyr-
omonas gingivalis strains are more virulent than non-encapsulated strains. Since difference
in virulence properties may be due to difference in cytokine production following recogni-
tion of the bacteria or their products by the host inflammatory cells, we compared cytokine
production following stimulation with bacteria or lipopolysaccharides (LPS) of a non-
encapsulated and an encapsulated P. gingivalis strain (K and K1).
Design: Tumour necrosis factor-alpha (TNF-a) production following stimulation of the cell-
line Mono Mac 6 with bacteria or LPS of both P. gingivalis strains was determined using flow
cytometry. Furthermore, we investigated the effects of the two P. gingivalis strains or their
LPS on TNF-a and Interleukin (IL-1b, IL-6, IL-12 and IL-10) production in whole blood using
Luminex. In both experiments, Escherichia coli bacteria and LPS were used as a reference.
Results: Both P. gingivalis strains induced lower cytokine production than E. coli with the
exception of IL-6. P. gingivalis K1 bacteria elicited a higher overall cytokine production than P.
gingivalis K. In contrast, P. gingivalis K1 LPS stimulation induced a lower cytokine production
than P. gingivalis K LPS.
Conclusions: Our findings suggest that the encapsulated P. gingivalis K1 bacteria induce
higher cytokine production than the non-encapsulated P. gingivalis K. This was not due
to its LPS. The stronger induction of cytokines may contribute to the higher virulence of P.
gingivalis K1.
# 2012 Elsevier Ltd. All rights reserved.
Available online at www.sciencedirect.com
journal homepage: http://www.elsevier.com/locate/aob1. Introduction
Periodontitis is a multifactorial, polymicrobial infection of the
tissues surrounding the teeth, caused by a mixed microflora* Corresponding author at: University Medical Center Groningen, Ce
Groningen, The Netherlands. Tel.: +31 50 3633165; fax: +31 50 363269
E-mail address: a.kunnen@umcg.nl (A. Kunnen).
0003–9969/$ – see front matter # 2012 Elsevier Ltd. All rights reserve
http://dx.doi.org/10.1016/j.archoralbio.2012.07.013consisting of gram-negative and gram-positive micro-organ-
isms. It is a chronic inflammatory disease involving complex
interactions between the micro-organisms and immune
response of the host and is characterised by collagen
destruction and alveolar bone resorption.1nter for Dentistry and Oral Hygiene, A. Deusinglaan 1, 9713 AV
6.
d.
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organism associated with periodontal breakdown and with
the capacity to modulate inflammatory responses is P.
gingivalis.2,3 Several encapsulated and non-encapsulated
serotypes of P. gingivalis have been described.4–6 Encapsu-
lated P. gingivalis serotypes are more virulent in experimen-
tal infections and cause a more invasive type of infection,
whereas non-encapsulated P. gingivalis cause a more local-
ised infection.7 The exact reason for the higher virulence of
encapsulated strains is not known, but may result from
different cytokine production following recognition of the
encapsulated or non-encapsulated bacteria by the host
immune system.8,9 P. gingivalis strains contain a variety of
components on their cell surface, like lipopolysaccharides
(LPS), lipoproteins and fimbriae, as well as capsular
components, which may activate inflammatory cells, such
as monocytes, and induce cytokine production.2 Especially
LPS is known as a potent stimulator of the host inflammatory
response10 and is thought to be a main virulence factor.2
Therefore, we hypothesised that encapsulated and non-
encapsulated P. gingivalis do induce different production of
cytokines upon stimulation of inflammatory cells and that
this may be due to their LPS.
Monocytes are the main regulators of the inflammatory
response11 by their ability to recognise bacteria and their
products by pattern recognition receptors (PRRs), like Toll-like
receptors (TLRs) and NOD-like receptors (NLRs).12 Upon
recognition of bacteria or their products by these PRRs,
monocytes start producing cytokines.13 In the present study,
we investigated whether encapsulated and non-encapsulated
P. gingivalis strains induced different cytokine production in
monocytes. First we used a monocyte cell line, Mono Mac 6
(MM6), to study whether there are differences in cytokine
responses of monocytes per se to the encapsulated and non-
encapsulated P. gingivalis strains. We used TNF-a as a marker
of cytokine production, since TNF-a is the most important
regulatory pro-inflammatory cytokine, which is first produced
by monocytes/macrophages upon bacterial or LPS stimula-
tion.14 Since this experiment showed different TNF-a
responses to especially the LPS of the two P. gingivalis strains,
in a second experiment, we incubated whole blood to simulate
the natural environment,15 with bacteria or LPS and measured
production of the pro-inflammatory cytokines TNF-a, IL-1b,
IL-6, IL-12 and the anti-inflammatory cytokine IL-10. In both
experiments, we used E. coli bacteria or its LPS as a reference,
since this species is known to be a strong inducer of pro-
inflammatory cytokines.16,17
2. Materials and methods
2.1. Experimental design
Experiment 1: The first aim was to compare the pro-
inflammatory properties of P. gingivalis K, P. gingivalis K1
and E. coli bacteria on monocytes per se. Therefore, we first
evaluated the production of TNF-a after stimulation of MM6
cells18 with the bacteria using flow cytometry. To study
whether differences in virulence are the result of differences
in pro-inflammatory potency of their LPS, we also determinedTNF-a production by MM6 cells after stimulation with LPS of P.
gingivalis (K and K1) as well as with E. coli LPS.
Experiment 2: Since in experiment 1 we found differences in
TNF-a production by MM6 cells after stimulation with the LPS of
the two P. gingivalis strains, we continued to study the production
of other pro- and anti-inflammatory cytokines, now using whole
blood, which simulates the in vivo situation better. For this
experiment,whole blood of15healthy individuals was stimulated
with bacteria as well as with LPS of P. gingivalis K, P. gingivalis K1
and E. coli. The production of TNF-a, IL-1b, IL-6, IL-12 and IL-10 was
measured using the Luminex system.
2.2. Bacterial strains and growth conditions
E. coli ATCC 25922 was grown on 5% sheep blood agar plates
(Mediaproducts, Groningen, The Netherlands) in air with 5%
carbon dioxide (CO2) at 37 8C for 1 day. Bacterial strains of P.
gingivalis ATCC 33277 (K), which has been shown to be non-
encapsulated19 and P. gingivalis W50 (K1), which has been
shown to have a capsule,6,20 were generously provided by A.J.
van Winkelhoff (Department of Oral Microbiology, Academic
Centre for Dentistry Amsterdam, The Netherlands). P. gingi-
valis K and K1 were grown on Brucella blood agar (Media-
products, Groningen, The Netherlands), supplemented with
5% sheep blood, 5 mg/l hemin and 1 mg/l menadione in an
anaerobic chamber with an atmosphere of 5% CO2, 10% H2 and
85% N2 at 37 8C. After 4–7 days, one bacterial colony per strain
was incubated in Todd–Hewitt broth (BBL Microbiology
Systems), supplemented with hemin (5 mg/l), menadione
(5 mg/l) and glucose (2 g/l) for one week. The bacterial cultures
were harvested by centrifugation at 2773  g for 10 min at 4 8C.
The supernatant was decanted and the bacterial pellet was
washed twice in phosphate-buffered saline (PBS). The number
of bacteria was evaluated by means of a microscope after
gram-staining and resuspended in PBS at a number corre-
sponding to approximately 1  108 bacteria/ml. All cultures
were stored at 20 8C until used.
Lipopolysaccharides derived from E. coli 055:B5 (BioWhit-
taker, Walkersville, MD, USA); P. gingivalis ATCC 33277 (Ultra-
Pure, Cat. #: tlrl-pglps, Lot. #: 28-06-PGLPS, InvivoGen, San
Diego, USA) and P. gingivalis W50, a generous gift from M.A.
Curtis (The Institute of Cell and Molecular Science, Barts and
The London School of Medicine and Dentistry, UK) were used.
2.3. Cell line and culture
The MM6 cell line was cultured in RPMI (Complete Roswell
Park Memorial Institute) 1640 medium (Invitrogen, California,
USA) with 10% foetal calf serum (FCS), supplemented with 1%
L-glutamine, 1% Na-pyruvate, 0.1% BME (2b-mercaptoethanol),
0.6% gentamycin sulfate and 0.05% fungizone (amfotericine B).
Cell-suspensions were cultured at 37 8C with a 5% CO2
humidified atmosphere and diluted 1:5 in the culture medium
for every 3–4 days.
2.4. Experiment 1: TNF-a production after stimulation of
MM6 cells
Before stimulation, MM6 cells were counted and diluted in RPMI
to a cell concentration of 4  109 cells/l. 2  108 MM6 cells/l were
a r c h i v e s o f o r a l b i o l o g y 5 7 ( 2 0 1 2 ) 1 5 5 8 – 1 5 6 61560supplemented with 9% FCS and 2 ng/ml monensin (Sigma
Aldrich, St. Louis, MO, USA) to inhibit intracellular transport of
TNF-a through the ER–Golgi complex.21 Immediately prior to
use, the stocks of 1  108 bacteria/ml of E. coli, P. gingivalis Kand
P. gingivalis K1 were thawed and used undiluted or diluted in PBS
(10, 100 and 1000 times). 250 ml of bacterial suspensions was
added to 50 ml of the MM6 suspension to reach a final bacterial
concentration in the tubes of 8.3  107, 8.3  106, 8.3  105 and
8.3  104 bacteria/ml respectively. All cultures were incubated
for 4 h at 37 8C in a 5% CO2 humidified atmosphere. Similarly,
MM6 cells were incubated with increasing concentrations
(0.005, 0.05, 0.25, 0.5, 1.0, 1.5 and 2.5 mg/ml) of P. gingivalis K
LPS, P. gingivalis K1 LPS or with E. coli LPS. For negative control
(unstimulated MM6 cells), MM6 cells were incubated in the
absence of bacterial or LPS challenge.
2.4.1. Sample labelling
After incubation, 200 ml of both stimulated and unstimulated
MM6 cells were fixed in 1 ml 2% paraformaldehyde (PFA) in PBS
for 5 min. Then, after centrifugation at 467  g for 5 min, the
pellet was resuspended in 1 ml 0.1% saponin solution (Sigma
Aldrich, St. Louis, MO, USA) in washing buffer [PBS with 0.5%
bovine serum albumin (BSA) and 0.1% sodium azide] for 5 min
in order to permeabilise the MM6 cells. After centrifugation
(5 min at 467  g) and aspiration, the cells were incubated with
PE-labelled mouse-anti-human TNF-a antibody (BD Pharmin-
gen, San Diego, USA), 1:10 diluted with 0.1% saponin solution
in washing buffer for 30 min at room temperature in the dark.
The MM6 cells were then washed again with 1 ml 0.1% saponin
solution in washing buffer, and after centrifugation and
aspiration, the cells were fixed with 200 ml 0.5% PFA in PBS
and were kept in the dark at 4 8C until measured by flow
cytometry, within 24 h after labelling.
2.4.2. Flow cytometry
MM6 cells were analysed using the FACS Calibur flow
cytometer (Becton Dickinson, NJ, USA). Flow cytometry results
were analysed using Winlist 6.0 software (Verity Software
House, Topsham, ME, USA).
2.4.3. Intracellular cytokines
Five thousand MM6 cells were acquired by live gating on the
total MM6 population using forward- and sidescatter char-
acteristics. This gate was copied to a single parameter
histogram, to determine intracellular TNF-a production of
the MM6 cells. Using the unstimulated control sample, a linear
gate was set in the histogram so that at least 99% of the
unstimulated MM6 cells were negative for TNF-a production.
This gate was then copied to the histogram for stimulated
MM6 cells. The percentage of positive cells was evaluated from
the histogram of the stimulated cells. Results are expressed as
percentage of TNF-a positive cells.
2.5. Experiment 2: cytokine production after stimulation
of whole blood
Whole blood samples were obtained by venous puncture from
15 healthy females. Protocols for this study were approved by
the local ethics committee and a written informed consent was
obtained from each subject before participation. Since malesand females do respond differently to endotoxin,22 in order to
obtain a homogenous study-population, only Caucasian wom-
en between 20 and 40 years of age, with no known systemic
diseases, were included in this study. Moreover, female
hormonal fluctuations during the different phases of the
ovarian cycle influence the sensitivity of monocytes to
endotoxin,23 therefore, for all individuals, blood was drawn in
the follicular phase of the menstrual cycle. Immediately after
blood sampling, all participants were submitted to a periodontal
examination by a certified dental hygienist (A.K.) using the
Dutch Periodontal Screening Index (DPSI) to establish the
periodontal condition.24 To avoid the risk of including partici-
pants with a generalised inflammatory response due to
periodontitis, we excluded subjects with a DPSI score of 3+ or
4, which is indicative for destructive periodontal disease.24
Blood samples (10 ml) were collected in vacutainer tubes
containing lithium heparin (Becton Dickinson, Rutherford, NJ,
USA). The stock bacterial cultures were thawed. Immediately
after sampling, 250 ml of undiluted stock bacterial cultures of
E. coli, P. gingivalis K or P. gingivalis K1 were mixed with 250 ml of
heparinised blood (final numbers: 5  107 bacteria/ml). Further-
more, 250 ml of heparinised whole blood was mixed with 250 ml
RPMI and LPS of E. coli, P. gingivalis Kor P. gingivalis K1 was added
(2 mg/ml). Negative controls were incubated in the absence of
bacterial or LPS challenge under similar circumstances. All
samples were incubated for 24 h at 37 8C in a 5% CO2humidified
atmosphere. After stimulation, all samples were pipetted into
1.5 ml Eppendorf tubes and centrifuged for 10 min at 316  g
(4 8C). The plasma was then pipetted into new 1.5 ml Eppendorf
tubes and centrifuged again for 5 min at 1972  g (4 8C).
Supernatants were frozen at 80 8C until cytokine concentra-
tions were measured using Luminex.
2.5.1. Determination of extracellular cytokine production in
whole blood
Cytokine levels in whole blood were measured using a Bio-
PlexTM premixed cytokine assay, human 5-plex group I; Cat. #:
M50019PLCW, control 5016683 (Bio-Rad Laboratories, Hercu-
les, USA). This customised kit simultaneously measured
human TNF-a, IL-1b, IL-6, IL-10 and IL-12 (p70). Standard
curves for each cytokine were generated using the reference
cytokine concentrations supplied in this kit. Assay buffer,
plasma and duplex standards were pipetted into the wells
according to the manufacturers’ instruction manual. In brief,
after prewetting the wells of a 96-well filter plate with assay
buffer, 50 ml of coupled beads were added to the wells and
washed twice with assay buffer using a vacuum manifold
(Millipore, MA, USA). 50 ml of 1:3 diluted plasma (sample
diluent supplied in the kit) and standards were pipetted into
the wells and incubated for 30 min with the coupled beads.
The wells were then washed three times and 25 ml of detection
antibody was subsequently added. After 30 min incubation,
the wells were again washed three times and incubated for
10 min with 50 ml streptavidin-PE. After 10 min of incubation,
the wells were washed three times in order to remove the
unbound streptavidin-PE. Finally, 125 ml of assay buffer was
added to each well after which the beads were analysed using
the Luminex LX100TM multiplex assay detection system. Raw
data (mean fluorescence intensity, MFI) were analysed using
STarStation V2.3.
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Statistical analysis was performed using GraphPad Prism 5 for
Windows (Graphpad Software, San Diego, CA, USA). Normality
tests were performed using the Shapiro–Wilk test. Values were
given as mean  standard error of the mean (SEM) for
normally distributed variables. Not normally distributed data
were presented as box and whisker plots showing the median
values, interquartile and full ranges of value. Outliers were
defined as data points greater than 1.5 the interquartile range
from the median value. To evaluate differences between the
dose response curves of the various bacterial and LPS
stimulations, we calculated the area under the curve (AUC).
Statistical comparisons between the AUCs after the various
bacterial and LPS stimulations were performed using the
unpaired Student’s t-test with Bonferroni’s correction. Differ-
ences in cytokine concentrations in plasma after stimulation
with the different bacterial species as well as after the
different LPS stimulations were evaluated by using Wilcoxon’s
Signed Rank test with Bonferroni’s correction. Pro- or anti-
inflammatory ratios were calculated by dividing the pro-
inflammatory cytokine production (TNF-a and IL-12) by the
anti-inflammatory cytokine production (IL-10). The ratios
between the various bacterial and LPS stimulations were
evaluated by using Wilcoxon’s Signed Rank test with
Bonferroni’s correction. For all experiments, a p-value of
<0.05 was accepted as statistically significant.
3. Results
3.1. Experiment 1: TNF-a production after stimulation of
MM6 cells
MM6 cells exposed to only medium showed no TNF-a producing
MM6 cells. Stimulation with increasing numbers of bacteria of P.Fig. 1 – (a) Mean W SEM percentages of TNF-a positive MM6 cells
P. gingivalis KS (Pg KS) or P. gingivalis K1 (Pg K1), with E. coli (Ec) as
positive MM6 cells after stimulation with increasing concentrat
strain. Insets: mean area under the curve (AUC) W SEM of TNF-a
numbers of bacteria from Pg KS, Pg K1 and Ec, or with increasin
Significantly different (unpaired Student’s t-test with Bonferrongingivalis K and P. gingivalis K1 showed a dose-dependent
increase in the percentage of TNF-a positive monocytes
(Fig. 1(a)). Differences in dose response curves after the various
bacterial stimulations were calculated using the AUC (Fig. 1(a),
inset). A significantly higher AUC was observed after stimula-
tion with bacteria of E. coli as compared with P. gingivalis K and
P. gingivalis K1 ( p < 0.05). No differences in the AUC between P.
gingivalis K and P. gingivalis K1 stimulation were observed.
The percentages of TNF-a positive MM6 cells increased
after stimulation with 0.005 mg/ml E. coli LPS, and then
remained constant following stimulation with higher con-
centrations (Fig. 1(b)). Stimulation with increasing concentra-
tions of P. gingivalis K LPS and K1 LPS induced a dose-
dependent increase of TNF-a positive MM6 cells, starting at
concentrations higher than 0.05 mg/ml LPS. As can be depicted
from Fig. 1(b) (inset), a significantly higher AUC was observed
after E. coli LPS stimulation as compared with both P. gingivalis
strains ( p < 0.05). Also, a significantly higher AUC after
stimulation with LPS of P. gingivalis K as compared with P.
gingivalis K1 was observed ( p < 0.05).
3.2. Experiment 2: cytokine production after stimulation
of whole blood
No cytokines were detected in plasma from unstimulated
blood samples (data not shown). Apart from IL-6 production
after P. gingivalis K1 stimulation, stimulation with E. coli
induced an overall higher cytokine production as compared
with P. gingivalis K and P. gingivalis K1 stimulation ( p < 0.05)
(Fig. 2). Furthermore, stimulation with P. gingivalis K resulted
in a significantly lower overall cytokine production than P.
gingivalis K1 ( p < 0.05, for all cytokines tested).
Cytokine production was higher after whole blood stimu-
lation with E. coli LPS, as compared with the LPS of P. gingivalis
K and P. gingivalis K1 ( p < 0.05, for all cytokines tested) (Fig. 3).
Stimulation with P. gingivalis K LPS induced a significant after stimulation with increasing numbers of bacteria from
 reference strain and (b) mean W SEM percentages of TNF-a
ions of LPS from Pg KS, Pg K1 and from Ec as reference
 positive MM6 cells after stimulation with increasing
g concentrations of LPS from Pg KS, Pg K1 and Ec. (*)
i’s correction; p < 0.05).
Fig. 2 – Median, 25th and 75th percentiles and 1.5 interquartile range (error bar) of secretion of TNF-a, IL-1b, IL-10, IL-12 and
IL-6 in human whole blood following stimulation with 5 T 107 bacteria/ml of E. coli (Ec), P. gingivalis KS (Pg KS) or P. gingivalis
K1 (Pg K1). Outlier values are represented as individual points: *. (*) Significantly different (Wilcoxon’s Signed Rank test
with Bonferroni’s correction; p < 0.05).
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( p < 0.05, for all cytokines tested).
3.2.1. Pro-/anti-inflammatory ratios
We observed that cytokine production was induced differently
following exposure to the various bacteria or LPS. Therefore,
we determined the ratio between pro-inflammatory and anti-
inflammatory cytokines after the various stimulations.Fig. 3 – Median, 25th and 75th percentiles and 1.5 interquartile r
IL-6 in human whole blood following stimulation with 2 mg/ml L
K1). Outlier values are represented as individual points: *. (*) S
Bonferroni’s correction; p < 0.05).The TNF-a/IL-10 ratios after both P. gingivalis bacterial
stimulations were lower than after E. coli stimulation ( p < 0.05)
(Fig. 4(a)). There were no differences in the TNF-a/IL-10 ratios
between the two P. gingivalis bacterial strains. Fig. 4(b) shows
the TNF-a/IL-10 ratios after the various LPS stimulations. No
differences in the TNF-a/IL-10 ratios were observed between
stimulation with LPS of E. coli as compared with both P.
gingivalis strains. However, a higher TNF-a/IL-10 ratio wasange (error bar) of secretion of TNF-a, IL-1b, IL-10, IL-12 and
PS of E. coli (Ec), P. gingivalis KS (Pg KS) or P. gingivalis K1 (Pg
ignificantly different (Wilcoxon’s Signed Rank test with
Fig. 4 – Median, 25th and 75th percentiles and 1.5 interquartile range (error bar) of TNF-a/IL-10 ratios: (a) following
stimulation with 5 T 107 bacteria/ml of E. coli (Ec), P. gingivalis KS (Pg KS) or P. gingivalis K1 (Pg K1) and (b) after stimulation
with 2 mg/ml LPS of Ec, Pg KS or Pg K1. Outlier values are represented as individual points: *. (*) Significantly different
(Wilcoxon’s Signed Rank test with Bonferroni’s correction; p < 0.05).
a r c h i v e s o f o r a l b i o l o g y 5 7 ( 2 0 1 2 ) 1 5 5 8 – 1 5 6 6 1563observed after P. gingivalis K LPS stimulation as compared
with P. gingivalis K1 ( p < 0.05).
IL-12 is an important pro-inflammatory cytokine associat-
ed with aggressive periodontal disease,25 forming a link
between innate and adaptive immunity.26 Therefore, we
calculated the ratios of IL-12/IL-10 after the various stimula-
tions. A significantly higher IL-12/IL-10 ratio was seen after
stimulation with E. coli bacterial stimulation as compared with
both P. gingivalis strains ( p < 0.05) (Fig. 5(a)). No significant
differences in the IL-12/IL-10 ratios between the two P.
gingivalis strains were observed after bacterial stimulation.
Fig. 5(b) shows the IL-12/IL-10 ratios after the various LPS
stimulations. There were no differences in the IL-12/IL-10
ratios between the various stimulations.Fig. 5 – Median, 25th and 75th percentiles and 1.5 interquartile ra
with 5 T 107 bacteria/ml of E. coli (Ec), P. gingivalis KS (Pg KS) or P
LPS of Ec, Pg KS or Pg K1. Outlier values are represented as ind
Signed Rank test with Bonferroni’s correction; p < 0.05).4. Discussion
This study was undertaken to investigate whether differences
in virulence properties between P. gingivalis K and P. gingivalis
K1 may be due to differences in their capacities to induce
cytokine production by monocytes. As expected, we showed
that bacteria and LPS of both P. gingivalis strains were less
potent inducers of cytokines as compared with our reference
strain E. coli. In line with our hypothesis, we found prominent
differences in cytokine production following incubation with
P. gingivalis K vs. P. gingivalis K1 bacteria or LPS. P. gingivalis K
bacteria in general induced a lower cytokine production as
compared with P. gingivalis K1. This difference cannot be duenge (error bar) of IL-12/IL-10 ratios: (a) following stimulation
. gingivalis K1 (Pg K1) and (b) after stimulation with 2 mg/ml
ividual points: *. (*) Significantly different (Wilcoxon’s
a r c h i v e s o f o r a l b i o l o g y 5 7 ( 2 0 1 2 ) 1 5 5 8 – 1 5 6 61564to differences in cytokine stimulation by their LPS, since P.
gingivalis K LPS induced a higher cytokine production as
compared with LPS of P. gingivalis K1.
The minor differences in results between experiments 1 and
2 can be explained by the use of different experimental
protocols, i.e. use of MM6 vs. whole blood, use of intracellular
cytokine production vs. extracellular production, 4 h stimula-
tion vs. 24 h. Despite these minor differences, in both experi-
ments, we found a higher overall cytokine production and
higher TNF-a/IL-10 and IL-12/IL-10 ratio after E. coli bacterial
stimulation as compared with P. gingivalis bacterial stimulation.
This higher pro-inflammatory cytokine production following
E. coli stimulation was expected, since it is a well-established
fact that E. coli is a more potent inducer of pro-inflammatory
cytokines than P. gingivalis both in vivo17 and in vitro.16 The
production of IL-6, however, appeared to be much more similar
between E. coli bacteria and the P. gingivalis species. This may
have an in vivo relevance, since IL-6 plays an important role in
regulating the immune response and leucocyte recruitment.27 It
also stimulates bone resorption by stimulating the formation
and activation of osteoclasts.28 IL-6 may therefore play an
important role in the pathogenesis of periodontal diseases.
In addition, the overall decreased production of all
cytokines by inflammatory cells after bacterial stimulation
with P. gingivalis K as compared with P. gingivalis K1 is in line
with previous findings.8,9 The higher total cytokine produc-
tion may play a role in the more invasive character of the
infection following P. gingivalis K1 infection in vivo. Increased
cytokine production may enhance the spreading of the
infection by activating other leucocytes in the environment
and by attacking these cells to the site of infection.28 Various
bacterial substances may be responsible for the differences in
cytokine induction after P. gingivalis K compared with P.
gingivalis K1 stimulation. The type of fimbriae of P. gingivalis
K1 (type IV fimA) has been reported to induce a much stronger
systemic inflammation in a mouse model as compared with
the type of fimbriae of P. gingivalis K (type 1 fimA).29
Differences in cysteine proteinase structure may also have
accounted for the observed variety in cytokine production
between the two P. gingivalis strains.30 Furthermore, the
presence of capsular polysaccharides in the bacterial sus-
pension of P. gingivalis K1 could have contributed to the
observed differences between the bacterial strains. The
capsule of P. gingivalis K1 has been shown to reduce
phagocytosis in vivo, providing the bacterium with a
mechanism to evade internalisation and clearance by host
inflammatory cells.31 A decreased phagocytosis of these
bacteria may result in increased numbers of bacteria which
can be recognised by monocytes, leading to increased
cytokine production. However, recent studies looking at
cytokine production by inflammatory cells after stimulation
with encapsulated P. gingivalis and non-encapsulated
mutants have shown higher cytokine production in the
non-encapsulated mutant.31,32 Additional in vivo studies are
thus needed to elucidate the role of the capsule of P. gingivalis
in host recognition and subsequent inflammatory responses.
Differences in chemical characterisation and biologic
properties of the LPS33 may also have played a role, since
the LPS is considered as one of the most important pro-
inflammatory molecules of gram-negative bacteria2. AlthoughE. coli LPS and P. gingivalis LPS differ in chemical structure of the
lipid A species,34 and signal through different Toll-like
receptors (TLR2 for LPS of P. gingivalis35 and TLR4 for LPS of
E. coli36,37), we found no differences in the IL-12/IL-10 and TNF-
a/IL-10 ratio between P. gingivalis LPS vs. E. coli LPS. Our results
are thus not in line with the suggestion that TLR2 is a weak
inducer of pro-inflammatory cytokines.38 It, however, corro-
borates the suggestion that TLR2 activation may also induce
strong type 1 helper T cell (TH1) responses
39 and indicates that
TLR2 activation may induce pro-inflammatory or immuno-
modulatory signalling.38,40
From our results, it is unlikely that LPS of the P. gingivalis
strains is responsible for the observed differences in cytokine
production following stimulation with P. gingivalis K and K1
bacteria. In contrast to P. gingivalis bacterial stimulation, we
observed a higher overall cytokine production after incubation
with P. gingivalis K LPS versus incubation with P. gingivalis K1
LPS and a higher TNF-a/IL-10 ratio. Our results are in agreement
with a study of Bramanti et al.33who also showed higher TNF-a
and IL-1b production after stimulation of inflammatory cells
with LPS of P. gingivalis K as compared with LPS of P. gingivalis
K1. This may be due to differences in the chemical properties of
the LPS between these two P. gingivalis strains, since variations
in carbohydrate and galactosamine composition and lipid A
proportion between the strains have been observed.33 There-
fore, our findings do not support the idea that the LPS of P.
gingivalis plays an important role in the observed variations in
virulence properties between the species.2 Other bacterial
products than LPS seem to be responsible for the higher
cytokine production following stimulation with P. gingivalis K1
bacteria compared with P. gingivalis K bacteria.
In summary, although E. coli bacteria were more potent
inducers of cytokine production in whole blood, we also
observed differences in cytokine production after stimulation
with P. gingivalis K vs. P. gingivalis K1: stimulation of whole
blood with the encapsulated P. gingivalis K1 bacteria resulted in
an overall higher cytokine production. This may be related to
the increased virulence of the encapsulated P. gingivalis strain,
since a higher cytokine production may result in the attraction
of more and other leucocytes and increase the spreading of the
inflammatory response. The reason why P. gingivalis K1 induced
a higher cytokine production remains elusive from the present
study, since the most obvious cytokine inducing substance
from gram-negative bacteria and thus P. gingivalis, its LPS, did
not induce a higher cytokine production as compared with LPS
from P. gingivalis K. Therefore, future studies need to be
directed towards identifying this mechanism as well as towards
revealing a causal relationship between the higher cytokine
production of P. gingivalis K1 and its higher virulence properties.
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